Related Experiment Video

Updated: May 29, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

New insights into HCV replication: potential antiviral targets

Charles M Rice1

  • 1Rockefeller University, New York, NY, USA.

Topics in Antiviral Medicine
|September 28, 2011
PubMed

Insights

Developing new hepatitis C virus (HCV) therapies involves understanding the viral life cycle and targeting viral or host factors. Research advances have accelerated the testing of antiviral agents for HCV eradication.

Area of Science:

  • Hepatology
  • Virology
  • Drug Development

Background:

  • Hepatitis C virus (HCV) infection remains a significant global health concern.
  • Eradication of HCV is the primary treatment objective.
  • Early research was limited by the inability to replicate HCV in cell culture.

Purpose of the Study:

  • To review the current understanding of the HCV life cycle.
  • To identify potential viral and host targets for novel HCV therapies.
  • To discuss advancements in HCV research and antiviral drug development.

Main Methods:

  • The article summarizes a presentation on HCV management and small molecule therapeutics.
  • It highlights key research advancements, including the HCV replicon and cell culture systems.
  • Potential therapeutic targets are identified based on the HCV life cycle.

Main Results:

  • Advances in cell culture systems have enabled rapid knowledge growth and accelerated antiviral testing.
  • Identified viral targets include entry factors (SR-B1, CD81), NS3/4A protease, NS5B polymerase, and others.
  • Host targets such as microRNAs and cyclophilins are also potential therapeutic avenues.

Conclusions:

  • Understanding the HCV life cycle is crucial for developing effective eradication strategies.
  • Numerous viral and host targets offer promising opportunities for new antiviral drug development.
  • Small molecule inhibitors represent a significant advancement in the new era of HCV treatment.

More Related Videos

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...